immunotherapy

17 July 2026

A young scientist will investigate new therapies for an untreatable hematological cancer thanks to the Medulizar project.

The Ágora program, on Aragón Radio, addresses the incorporation of Lorena Sancho into the Immunotherapy, Infection, Inflammation and Cancer group of the IIS Aragón.
2 March, 2026

A breakthrough from Aragon opens new avenues of immunotherapy for rare blood diseases

A preclinical study by the IIS Aragón demonstrates, for the first time, the viability of a CAR-T therapy aimed at myeloproliferative neoplasms (rare blood diseases with limited therapeutic options).
25 February, 2026

The Cuenca Villoro Foundation's 2025 Grant supports a project by the IIS Aragón on high-risk neuroblastoma

Endowed with 50.000 euros, this year's call supports the project led by Ariel Gaspar Ramírez Labrada, from the Immunotherapy, Inflammation, Infection and Cancer (I3C) group of the IIS Aragón.
16 April 2025

Julián Pardo Jimeno: “It is essential to collaborate with the right professionals and work in multidisciplinary teams.”

In this interview, the IIS Aragón researcher talks about his work leading the 'Immunotherapy, Inflammation, Infection and Cancer (I3C)' group (GIIS055) and the main challenges they face.
6 February, 2025

A project brings cancer researchers into the classroom

The fifth edition of 'Get to Know Them' by the Spanish Association for Cancer Research (ASEICA) "puts 350 female cancer researchers on the map", ten of them from the IIS Aragón, to reach schools and universities throughout Spain.